746 related articles for article (PubMed ID: 12722822)
1. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
Medich DC; Munro JJ
Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
[TBL] [Abstract][Full Text] [Related]
3. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
Duggan DM
Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
5. Brachytherapy dosimetry parameters calculated for a new 103Pd source.
Rivard MJ; Melhus CS; Kirk BL
Med Phys; 2004 Sep; 31(9):2466-70. PubMed ID: 15487726
[TBL] [Abstract][Full Text] [Related]
6. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
7. Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source.
Li Z; Palta JR; Fan JJ
Med Phys; 2000 May; 27(5):1108-12. PubMed ID: 10841416
[TBL] [Abstract][Full Text] [Related]
8. Influence of photon energy spectra from brachytherapy sources on Monte Carlo simulations of kerma and dose rates in water and air.
Rivard MJ; Granero D; Perez-Calatayud J; Ballester F
Med Phys; 2010 Feb; 37(2):869-76. PubMed ID: 20229896
[TBL] [Abstract][Full Text] [Related]
9. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
Chan GH; Prestwich WV
Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
11. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D;
Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
[TBL] [Abstract][Full Text] [Related]
14. Dose rate constants for 125I, 103Pd, 192Ir and 169Yb brachytherapy sources: an EGS4 Monte Carlo study.
Mainegra E; Capote R; López E
Phys Med Biol; 1998 Jun; 43(6):1557-66. PubMed ID: 9651025
[TBL] [Abstract][Full Text] [Related]
15. Well-ionization chamber response relative to NIST air-kerma strength standard for prostate brachytherapy seeds.
Mitch MG; Zimmerman BE; Lamperti PJ; Seltzer SM; Coursey BM
Med Phys; 2000 Oct; 27(10):2293-6. PubMed ID: 11099196
[TBL] [Abstract][Full Text] [Related]
16. Monte Carlo aided design of an improved well-type ionization chamber for low energy brachytherapy sources.
Bohm TD; Micka JA; DeWerd LA
Med Phys; 2007 Apr; 34(4):1274-85. PubMed ID: 17500459
[TBL] [Abstract][Full Text] [Related]
17. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
19. A semi-analytic approach to determine dose rate constant of brachytherapy sources in compliance with AAPM TG 60 formalism.
Selvam TP; Nagarajan PS; Rajan KN; Sethulakshmi P; Bhatt BC
Australas Phys Eng Sci Med; 2003 Dec; 26(4):179-84. PubMed ID: 14995063
[TBL] [Abstract][Full Text] [Related]
20. Polymer gel dosimetry close to an 125I interstitial brachytherapy seed.
Pantelis E; Lymperopoulou G; Papagiannis P; Sakelliou L; Stiliaris E; Sandilos P; Seimenis I; Kozicki M; Rosiak JM
Phys Med Biol; 2005 Sep; 50(18):4371-84. PubMed ID: 16148399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
